gimli

KOVAI stock AI analysis

KOVAI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

KOVAI MEDICAL CENTER & HO is a small-cap stock in Healthcare. This Gimli page shows the latest available KOVAI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive KOVAI stock page

Price

₹6,226.00

1W return

-1.05%

1M return

+3.54%

3M return

+6.11%

6M return

n/a

1Y return

n/a

Market cap

₹6,812.68 cr

26.96

5.16

ROE

+21.01%

ROCE

+23.06%

RSI

58.13

Turnover

₹2.01 cr

Why it can matter in screens

Momentum: KOVAI is above 50DMA, below 200DMA; RSI is 58.13.
Returns: 1D +1.87%, 1W -1.05%, 1M +3.54%, 3M +6.11%, 1Y n/a.
Trend levels: 52W high ₹6,444.00, 52W low ₹5,275.50, off high -3.38%.
Liquidity: latest turnover is ₹2.01 cr; volume vs 20D is +0.67%.
Valuation/profitability: PE 26.96, PB 5.16, ROE +21.01%, ROCE +23.06%.
Growth: 3Y sales CAGR +18.24%, 3Y profit CAGR +28.29%.

Quick Answers

What is the latest KOVAI stock price?

The latest stored price for KOVAI is Rs 6,226.00 as of 2026-09-18.

Is KOVAI above its 50DMA and 200DMA?

KOVAI is above 50DMA, below 200DMA. The latest 50DMA is 5,989.76 and the latest 200DMA is n/a.

What are KOVAI PE, ROE and ROCE?

KOVAI has PE 26.96, ROE +21.01%, and ROCE +23.06% in Gimli's latest available snapshot.

How has KOVAI performed recently?

KOVAI has returned +3.54% over 1 month, +6.11% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	438.65 cr	131.28 cr	69.09 cr	63.14
2026-03-31	413.20 cr	119.05 cr	59.69 cr	54.55
2025-12-31	406.62 cr	123.16 cr	65.02 cr	59.42
2025-09-30	390.74 cr	113.41 cr	58.86 cr	53.79
2025-06-30	373.59 cr	111.49 cr	57.23 cr	52.30
2025-03-31	356.64 cr	107.48 cr	54.70 cr	49.99
2024-12-31	354.70 cr	108.91 cr	57.80 cr	52.83
2024-09-30	n/a	n/a	n/a	46.32

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	1,584.15 cr	467.10 cr	244.46 cr	223.41
2025-03-31	1,369.74 cr	407.82 cr	208.95 cr	190.95
2024-03-31	1,133.84 cr	362.48 cr	179.73 cr	164.25
2023-03-31	958.19 cr	284.32 cr	115.77 cr	105.80
2022-03-31	917.82 cr	269.34 cr	104.26 cr	95.28

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	2,066.08 cr	63.72 cr	402.75 cr	1,319.27 cr
2025-03-31	1,799.91 cr	14.30 cr	415.34 cr	1,086.16 cr
2024-03-31	1,438.23 cr	59.60 cr	310.36 cr	888.54 cr
2023-03-31	1,438.12 cr	17.95 cr	510.91 cr	719.04 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	361.83 cr	109.88 cr	n/a
2025-03-31	352.91 cr	-0.18 cr	n/a
2024-03-31	344.13 cr	205.71 cr	n/a
2023-03-31	262.91 cr	135.52 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	440,829.82 cr	36.388220	+15.50%	+11.45%
DIVISLAB	DIVI S LABORATORIES LTD	248,876.81 cr	85.407280	+18.37%	+53.39%
TORNTPHARM	TORRENT PHARMACEUTICALS L	163,807.57 cr	75.106636	+17.33%	+35.67%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	128,608.22 cr	65.670049	+21.03%	+13.94%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	116,723.14 cr	26.011308	+16.04%	+10.70%
CIPLA	CIPLA LTD	112,647.78 cr	33.401961	+10.25%	-11.64%
LAURUSLABS	LAURUS LABS LIMITED	105,487.98 cr	96.587446	+21.77%	+111.64%
MAXHEALTH	MAX HEALTHCARE INS LTD	102,122.47 cr	70.799892	+14.33%	-10.58%

Try these prompts

Analyze KOVAI MEDICAL CENTER & HO with valuation, momentum and industry peers
Compare KOVAI with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-09-18. Not investment advice.